Green Elephant Biotech announces the market introduction of Archimedes® One, the first system in a new category called the Dynamic Adherent Bioreactor. The company is introducing the platform to the ...
NEW YORK/FRANKFURT (Reuters) - Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 billion to add rare cancer therapies ahead of ...
CEO Krish Krishnan opened the call highlighting the continued momentum in the VYJUVEK launch. He stated, "In Q3, VYJUVEK launch continued to build momentum and the updated U.S. label clearly ...
Anbio Biotechnology (NASDAQ: NNNN) ("Anbio" or the "Company"), a global diagnostic company in in-vitro diagnostic (IVD) technologies, announced today that its CEO will participate in the upcoming ...
Nisha Gopalan is a former Senior Overnight Assignment Editor for Investopedia News. She is an award-winning financial journalist who has worked in London, where she is currently based, and Hong Kong.
CEP certification confirms Brains Bio’s naturally-derived CBD pharmaceutical ingredient meets European Pharmacopoeia standards, providing a significant regulatory advantage for drug developers and ...
At today's Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all agenda items with a broad majority. Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results